Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia
Clinical trial NCT00133991 · COMPLETED
Trial details
- NCT number
- NCT00133991
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2011-08-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.